Non-medical marijuana use was linked to worse depression and higher suicidal thoughts over time

This was a longitudinal study of 307 psychiatry outpatients participating in a trial of drug/alcohol use treatment for depression. Past 30-day marijuana use (medical and non-medical), depression/anxiety symptoms, psychiatry visits, and functional health status were measured at baseline, 3, 6, and 12 months. Regression and growth curve models compared outcomes across medical users, non-medical users, and non-users.

Many people with depression use marijuana for relief, but this study suggests that non-medical use may actually impede recovery. The combination of worse symptom trajectories and fewer psychiatry visits creates a double risk: the condition may worsen while treatment engagement declines. This has practical implications for clinicians treating depression in marijuana-using patients.

The distinction between medical and non-medical marijuana use in depression is clinically relevant but often overlooked. This study suggests the two patterns may have different implications for mental health outcomes, with non-medical use potentially serving as a form of avoidant coping that substitutes for professional treatment rather than complementing it.

Participants were psychiatry outpatients, limiting generalizability to the broader depressed population. The observational design cannot determine whether marijuana caused worse outcomes or whether more severely depressed patients were more likely to use marijuana non-medically. Self-reported marijuana use and categorization as medical versus non-medical may be unreliable. The study did not control for dose, frequency, or THC/CBD content.